🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans

Kelly Shi

Stock Analyst at Jefferies

(3.84)
# 1,978
Out of 5,152 analysts
231
Total ratings
43.8%
Success rate
6%
Average return

Stocks Rated by Kelly Shi

ImmunityBio
Oct 14, 2026
Reiterated: Buy
Price Target: $8 → $14
Current: $6.70
Upside: +108.96%
ArriVent BioPharma
Oct 6, 2026
Reiterated: Buy
Price Target: $35 → $18
Current: $10.90
Upside: +65.14%
Insmed
Dec 18, 2025
Reiterated: Buy
Price Target: $230 → $219
Current: $119.80
Upside: +82.80%
PTC Therapeutics
Oct 28, 2025
Reiterated: Buy
Price Target: $63 → $77
Current: $60.23
Upside: n/a
Immunocore Holdings
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $48
Current: $27.51
Upside: n/a
Viridian Therapeutics
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $44
Current: $30.12
Upside: n/a
Zai Lab
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $52
Current: $22.11
Upside: n/a
Ascendis Pharma
Jul 29, 2025
Reiterated: Buy
Price Target: $233 → $235
Current: $270.33
Upside: n/a
Cogent Biosciences
Jul 7, 2025
Reiterated: Buy
Price Target: $20 → $28
Current: $27.81
Upside: n/a
Kymera Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $59 → $64
Current: $121.13
Upside: n/a
Reiterated: Buy
Price Target: $75 → $82
Current: $117.80
Upside: n/a
Reiterated: Buy
Price Target: $43
Current: $8.56
Upside: n/a
Reiterated: Buy
Price Target: $19
Current: $6.87
Upside: n/a
Reiterated: Buy
Price Target: $44
Current: $10.50
Upside: n/a
Reiterated: Buy
Price Target: $91
Current: $16.25
Upside: n/a
Reiterated: Buy
Price Target: ¥5,100
Current: ¥6,897
Upside: n/a
Reiterated: Buy
Price Target: $24 → $6
Current: $0.6711
Upside: n/a
Downgraded: Sell
Price Target: $1
Current: $0.015
Upside: n/a
Reiterated: Buy
Price Target: $40 → $30
Current: $19.82
Upside: n/a
Reiterated: Buy
Price Target: $56 → $42
Current: $3.11
Upside: n/a
Reiterated: Buy
Price Target: $286
Current: $403.60
Upside: n/a
Reiterated: Buy
Price Target: $58 → $40
Current: $10.46
Upside: n/a
Reiterated: Buy
Price Target: $13 → $10
Current: $1.37
Upside: n/a
Upgraded: Buy
Price Target: $11 → $52
Current: $5.43
Upside: n/a
Reiterated: Buy
Price Target: $73 → $86
Current: $159.82
Upside: n/a
Rated: Buy
Price Target: $18 → $14
Current: $1.79
Upside: n/a
Reiterated: Buy
Price Target: $107 → $23
Current: $12.00
Upside: n/a
Reiterated: Buy
Price Target: $65
Current: $10.79
Upside: n/a
Rated: Buy
Price Target: $20
Current: $6.10
Upside: n/a
Downgraded: Hold
Price Target: $26 → $3.5
Current: $1.82
Upside: n/a
Reiterated: Buy
Price Target: $11 → $13
Current: $1.06
Upside: n/a
Initiated Coverage: Buy
Price Target: $21
Current: $3.77
Upside: n/a
Downgraded: Hold
Price Target: $120 → $7
Current: $6.40
Upside: n/a
Reiterated: Buy
Price Target: $7.00
Current: $5.33
Upside: n/a
Rated: Buy
Price Target: $15 → $6
Current: $1.04
Upside: n/a
Reiterated: Buy
Price Target: $11 → $14
Current: $2.48
Upside: n/a
Reiterated: Buy
Price Target: $75 → $5
Current: $0.9031
Upside: n/a
Initiated Coverage: Buy
Price Target: $36
Current: $1.06
Upside: n/a
Reiterated: Buy
Price Target: $27 → $8
Current: $2.50
Upside: n/a
Reiterated: Buy
Price Target: $14
Current: $1.03
Upside: n/a
Reiterated: Buy
Price Target: $27 → $7
Current: $0.6652
Upside: n/a
Initiated Coverage: Buy
Price Target: $20
Current: $9.07
Upside: n/a
Rated: Buy
Price Target: $25 → $23
Current: $0.273
Upside: n/a
Initiated Coverage: Buy
Price Target: $52
Current: $13.99
Upside: n/a
Rated: Buy
Price Target: $53
Current: $0.6959
Upside: n/a
Initiated Coverage: Buy
Price Target: $27
Current: $3.81
Upside: n/a
Rated: Buy
Price Target: $63
Current: $1.36
Upside: n/a